Global Orphan Cancer Drug Market Report 2022-2028
July 12, 2022 06:48 ET
|
Research and Markets
Dublin, July 12, 2022 (GLOBE NEWSWIRE) -- The "Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
Antibody Drug Conjugate Market, a $13.15 billion Industry by 2030 with a CAGR of 14.12 %
June 21, 2022 04:54 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- The surge in the antibody-drug conjugates market growth is due to rising cancer cases globally, technological advancements in medical...
Global HPAPIs and Cytotoxic Drugs Manufacturing Market Research Report 2022
June 15, 2022 08:13 ET
|
Research and Markets
Dublin, June 15, 2022 (GLOBE NEWSWIRE) -- The "HPAPIs and Cytotoxic Drugs Manufacturing Market, by Drug Origin, by Manufacturing Location, by Drug Type, by Type of Pharmacological Molecule, by...
Global Antibody Partnering Deal Terms and Agreements Directory/Report 2022: Access to 1900 Deals and Contract Documents Entered into by the Worlds Leading Healthcare Companies
June 08, 2022 03:28 ET
|
Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Global Antibody Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Global Antibody Partnering...
Global Antibody Therapy Market Research Report 2022: Analysis & Forecasts, 2014-2021 & 2022-2032: mAbs, Oncology, Autoimmune, Infectious Diseases, Antibody-drug Conjugates ADCs
May 24, 2022 06:08 ET
|
Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Antibody Therapy Market" report has been added to ResearchAndMarkets.com's offering. A recent market study on the market offers global industry analysis...
Global Oncology Antibody Drug Conjugates Market Size
April 28, 2022 09:15 ET
|
Global Market Estimates
Brooklyn, New York, April 28, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is...
Elucida Oncology’s Lead Clinical Candidate ELU001 to Be Featured in Two Abstracts at the American Association for Cancer Research Annual Meeting
April 04, 2022 10:00 ET
|
Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company developing the next frontier in targeted cancer therapy, announced today two...
$5.9 Billion Worldwide Antibody Drug Conjugates Industry to 2031 - Identify Growth Segments for Investment
March 22, 2022 05:28 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2022: By Type, By Application, By Product, By Technology, By End-User" report has been added to...
Global Cancer Antibody Drug Conjugate Markets, Forecast to 2028 - Sales Trends; Clinical Insights; Dosage, Price & Patent Insights; Quarterly & Yearly Drug Sales; Competitive Landscape and More
March 02, 2022 06:13 ET
|
Research and Markets
Dublin, March 02, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
Antibody Drug Conjugates (ADCs) Market Size to Reach USD 13.17 Billion by 2028 - Powered by Approval for Biologics License Applications – Vantage Market Research
February 15, 2022 04:39 ET
|
Vantage Market Research
WASHINGTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Antibody Drug Conjugates (ADCS) Market finds that granted accelerated approval for biologics...